TECHNOLOGY

Lattice Medical is a biomedical start-up that was launched in October 2017
Patented 3D technology developed with CHU Lille-France that allows adipose tissue to naturally regenerate

APPLICATIONS

THE MAT(T)ISSE BIOPROTHESIS:
A BIO-RESORBABLE TEC
(TISSUE ENGINEERING CHAMBER)

RESORBABLE CHAMBER

Designed and made
with 3D printed biomaterials

Adapted to the individual morphology of patients

Fully degrades
in a year

PATIENT AUTOLOGOUS ADIPOSE TISSUE GRAFTING

Vascular adipose flap tissue inlaid
over the Tissue Engineering Chamber (TEC)

Guided tissue
reconstruction

Regenerates patients’
adispose cells

The desired size is reached after just one surgery: breasts are entirely reconstructed by the patient’s tissues, and no foreign bodies are introduced.

SUBCUTANEOUS TISSUE
AND FACIAL RECONSTRUCTION

Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.

Following surgery, serious burns, chronic wounds, and accidents, traumatized soft tissue needs to be repaired.

In collaboration with CHU Lille, Lattice Medical provides product design, R&D services, and various solutions for soft tissue engineering and regeneration. Alongside textile manufacturing partners, we develop textile matrixes (including Calais lace ones) that are obtained through the Leavers method.

Lattice Medical offers sub-licensing R&D contracts to manufacturers and provides pre-clinical proof-of-concept studies.

SOFT TISSUE RECONSTRUCTION PLATFORM

A new era in medical application development

Thanks to its integrated platform, Lattice Medical is able to offer innovative solutions and the opportunity for biomedical projects to explore new technological landscapes. Lattice Medical is helping manufacturers in the medical procedure industry with their transition towards 3D technology.
Lattice Medical is developing the first ISO 13485 production in clean room with 3D printing for designing personalized implantable resorbable medical devices.
This unique platform is endowed with new 3D printing and extrusion technology that is able to produce prototypes, pre-series and industrial series for R&D trials, pre-clinical and clinical studies at extremely low particular pollution levels.

More information available on https://lattice-services.com/

SERVICES

SITEDRUG

Interreg 2 Seas project “Site-Specific Drug Delivery” (Site Drug)

E-SHOP

FILAMENTS FOR 3D PRINTING

Want to test specific medical grade polymers for R&D purpose in 3D printing medical area such as tissue engineering, custom medical devices or 3D printed prototypes. Try our filaments for 3D printing.

 

NEW : See our new website dedicated to 3D Printing Filaments and 3D printing for medical devices – https://lattice-services.com/

TEAM

j-bax-lattice-medical

Justine Bax

Quality and Regulatory Affairs
k-roux-lattice-medical

Kévin ROUX

Process Engineer
s-cao-lattice-medical

Shengheng Cao

Biomedical Engineer
pm-danze-lattice-medical

Dr. Pierre-Marie Danzé

Biochemist and Scientific Advisor
j-destouesse-villa-lattice-medical

Jaime Destouesse-Villa

Mechanical Engineer
m-gradwohl-lattice-medical

Marion Gradwohl

Material Engineer
p-guerreschi-lattice-medical

Pr. Pierre Guerreschi

Plastic and Reconstructive Surgeon and Scientific Advisor
p-marchetti-lattice-medical

Pr. Philippe Marchetti

Biologist and Scientific Advisor
DCL Visage NB

Damien Cleret

Pre-clinical Studies
j-payen-lattice-medical

Julien Payen

CEO, Co-founder
783A2363ok-blackwhite

Zelzima Amelia Jordao

Biology Engineer
JSE Visage NB

Jérôme Segers

Quality Engineer
SBO Visage NB

Siham Bouyouaaran

Human Ressources
CGI Visage NB

Chloé Gigon

Industrialisation Engineer
783A2356ok-blackwhite

Mégann Le Rest

Biomaterials Engineer
783A2398ok-blackwhite

Lou Pasquier

Methods Engineer
Guillaume Bruniaux

Guillaume Bruniaux

Mission Director at SIPAREX for Nord France Amorçage
Hélène-Cannard

Hélène Cannard

Member of the executive management at FINOVAM GESTION
FRANCOIS_MARTIN v2

François Martin

Associate Partner with Schnopp & Partner
n-blanchemain-lattice-medical

Nicolas Blanchemain

Assistant Professor at Lille University, Biomaterials, Medical Devices and Drug Delivery
Mathias Brieu

Pr. Mathias Brieu

Professor at Cal State Los Angeles, Mechanical Engineering
team-member

Pr. Xavier Garric

Professor at Montpelier University, Artificial Biopolymers
Nicolas Leymarie

Dr. Nicolas Leymarie

Plastic and Reconstructive Surgeon, Gustave Roussy
Isabelle Martinache

Isabelle Martinache

Tissue referring doctor, French Biomedicine Agency
Michel Toungouz

Pr. Michel Toungouz

Center for Tissue and Cell Therapy, Head of Clinic, Saint Luc and Bruxelles University

PRESS REPORT

PRESS RELEASE - LATTICE MEDICAL announces the closing of a €8 million Series A financing round

Lille, October 1, 2022 – LATTICE MEDICAL, announces the closing of a second round of financing of 8 million euros. This round was led by the historical funds Finovam Gestion, Nord France Amorçage and WiSEED alongside the Captech Santé fund. The European Commission, via its EIC Fund, and Santelys are co-investing. The financing round is completed by non-dilutive financing, in the form of a grant and debt from BPIFrance and the EIC accelerator.

More information on presse release below:

SUCCESS OF THE FIRST BREAST RECONSTRUCTION SURGERY WITH MATTISSE

|SUCCESS OF THE FIRST BREAST RECONSTRUCTION SURGERY WITH MATTISSE 🚀|

On July 12, 2022, a first patient with breast cancer was able to undergo breast reconstruction with our #MATTISSE implant. The surgery took place at the Institute of Clinical Oncology in Tbilisi, Georgia.

It was conducted by Professor Gia Nemsadze and his team, and in the presence of the co-founders of Lattice Medical, Professor Pierre Guerreschi, Professor Philippe Marchetti, (both PUPH at the University Hospital of Lille) and Mr Julien Payen.

Two months after the operation, the healing is complete and the patient is in very good health.

More information in the press release below 👇

Lattice Medical Launches its Clinical Trials

|LATTICE MEDICAL LAUNCHES ITS CLINICAL TRIALS 🚀|
And here we are! After 3 years of work, we announce the start of our clinical trials and the inclusion of a first patient eligible for breast reconstruction with #MATTISSE for her breast cancer.
This is a world first 🏆for this type of technology, #madeinfrance totally resorbable, 3D printed, allowing a natural breast reconstruction, with a simple and unique surgery.
We hope to provide an alternative to current silicone implants and techniques used in #breastreconstruction. Thanks to the The Guardian newspaper for announcing this exclusive in their article on Sunday: https://lnkd.in/e4gH49TB
This is a real recognition of the quality work undertaken by the LATTICE MEDICAL team for over 3 years, recognised and published in three peer-reviewed journals. Thank you to all our partners and investors who have supported us since the beginning of the adventure to achieve this first!
More information in the press release.

 

NEWS

Lattice Medical lance sa collecte WiSEED en vue de financer ses essais cliniques !

🐱‍🏍3 ans après sa première levée de fonds, Lattice Medical relance une nouvelle collecte dans l’objectif principal de financer le premier essai clinique de l’implant MATTISSE afin de faire bénéficier d’une reconstruction mammaire naturelle, simple et sans risque aux femmes ayant eu une mastectomie dans leur traitement du cancer du sein.

👍Nous tenons à remercier l’équipe de gestion de WiSEED de refaire confiance à l’équipe Lattice Medical qui a franchi de grandes étapes lors de ces trois dernières années.

💖Et nous remercions d’ores et déjà toute la communauté des WiSEEDers qui font et referont confiance dans notre projet.

N’hésitez pas à poser vos questions, commenter et partager notre collecte, notre ambition reste la même : remplacer les implants silicones et aider 40 000 femmes d’ici 2030 à avoir une reconstruction mammaire plus simple et sans risques. 🙌

https://www.wiseed.com/fr/projet/35925174-lattice

AVRIL 2021: LATTICE MEDICAL RECRUTE UN STAGE GRAPHISTE ET WEBDESIGN

Lattice Medical recrute un ou une étudiante  de formation graphiste webdesigner en stage pour réaliser  la création d’animations de chirurgie pour l’implant MATTISSE, de graphismes et illustrations et optimiser et mettre à jour notre site internet Lattice médical»

Contact : recrutement@lattice-medical.com
L’offre : Offre Stage Webdesigner

APRIL 2021: LATTICE MEDICAL IS RECRUITING ITS NEW REGULATORY AND QUALITY MANAGER

Do you want a new challenge ?

We Hiring !
“Quality and Regulatory affairs Manager”

In order to register our medical device initially in Europe, the USA and internationally, we need a leader who can manage all the regulatory elements, obtain and maintain the CE/FDA mark, establish the link with the regulatory authorities, notified body as well as the experienced Q / AR consultants.
Manage the regulatory/quality team, support the implementation of ISO 13485 certification and drive the clinical evaluation plan for our first-in-human in 2022.

So join us !
Contact : recrutement@lattice-medical.com
Quality Regulatory Affairs Manager – 2021 VA

PARTNERS

CONTACT

LATTICE MEDICAL

80 rue du Dr. Yersin
59120 Loos